Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays.

de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V. · 2009

Read Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. by de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2761376.txt.

Description

de Jager and co-authors set out in 2009 the prerequisites for measuring cytokines in clinical trials. Cytokines are immune signal proteins. Multiplex immunoassays read many cytokines from one sample. Such measures can track whether antibody drugs hit their immune targets in patients. Trivial handling steps, they warn, can badly distort the low natural levels.

Spiking known cytokine amounts into blood samples, they found recoveries mostly within eighty to one hundred twenty percent. Most cytokines stayed stable for up to two years frozen, but several fell sharply by four years. Only two of fifteen cytokines survived repeated freeze-thaw cycles well. They also demonstrate an internal control, and stress tube choice and storage rules for trials.

Catalog record

CREATORde Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2761376

Browse the full library · About the Tower of Babel